{
    "id": 26135,
    "fullName": "FGFR2 L617V",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FGFR2 L617V (also referred to as V618V from the FGFR2IIIb isoform) lies within the protein kinase domain of the Fgfr2 protein (UniProt.org). L617V has been shown to confer resistance to Fgfr inhibitors in cell culture (PMID: 28034880), and demonstrates increased Fgfr2 kinase activity compared to wild-type in vitro (PMID: 28166054), and therefore, is predicted to result in a gain of Fgfr2 protein function.",
            "references": [
                {
                    "id": 14787,
                    "pubMedId": 28166054,
                    "title": "Elucidation of a four-site allosteric network in fibroblast growth factor receptor tyrosine kinases.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28166054"
                },
                {
                    "id": 8146,
                    "pubMedId": 28034880,
                    "title": "Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28034880"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2263,
        "geneSymbol": "FGFR2",
        "terms": [
            "FGFR2",
            "BBDS",
            "BEK",
            "BFR-1",
            "CD332",
            "CEK3",
            "CFD1",
            "ECT1",
            "JWS",
            "K-SAM",
            "KGFR",
            "TK14",
            "TK25"
        ]
    },
    "variant": "L617V",
    "createDate": "03/07/2017",
    "updateDate": "05/30/2019",
    "referenceTranscriptCoordinates": {
        "id": 90200,
        "transcript": "NM_000141",
        "gDna": "chr10:g.121496546A>C",
        "cDna": "c.1849T>G",
        "protein": "p.L617V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10148,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, FGFR2 mutations E565A, K641R, L617V, N549H and V564F were identified in the cell-free DNA of a cholangiocarcinoma patient harboring FGFR2-OPTN fusion after the patient progressed while on Infigratinib (BGJ398) treatment (PMID: 28034880).",
            "molecularProfile": {
                "id": 27312,
                "profileName": "FGFR2 - OPTN FGFR2 N549H FGFR2 V564F FGFR2 E565A FGFR2 L617V FGFR2 K641R"
            },
            "therapy": {
                "id": 674,
                "therapyName": "BGJ398",
                "synonyms": null
            },
            "indication": {
                "id": 4947,
                "name": "cholangiocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 8146,
                    "pubMedId": 28034880,
                    "title": "Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28034880"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27310,
            "profileName": "FGFR2 L617V",
            "profileTreatmentApproaches": [
                {
                    "id": 19592,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR2 L617V"
                },
                {
                    "id": 19593,
                    "name": "FGFR2 Inhibitor",
                    "profileName": "FGFR2 L617V"
                }
            ]
        },
        {
            "id": 27312,
            "profileName": "FGFR2 - OPTN FGFR2 N549H FGFR2 V564F FGFR2 E565A FGFR2 L617V FGFR2 K641R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 90203,
            "transcript": "XM_006717712",
            "gDna": "chr10:g.121485456G>C",
            "cDna": "c.1849C>G",
            "protein": "p.L617V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 90202,
            "transcript": "XM_017015925",
            "gDna": "chr10:g.121485447G>C",
            "cDna": "c.1849C>G",
            "protein": "p.L617V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 90201,
            "transcript": "NM_001144916",
            "gDna": "chr10:g.121485396G>C",
            "cDna": "c.1849C>G",
            "protein": "p.L617V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 90200,
            "transcript": "NM_000141",
            "gDna": "chr10:g.121496546A>C",
            "cDna": "c.1849T>G",
            "protein": "p.L617V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}